< Back to latest news & events

News

Oral Proceedings by videoconference (VICO) in oppositions proceedings to become permanent

November 2022

The pilot project for oral proceedings in opposition proceedings by video conference (VICO) started during the pandemic and has received positive feedback.[1]

The President of the EPO has therefore declared (Decision of 22 November 2022) that, as of 1 January 2023, VICOs will become the default format for oral proceedings in opposition. Only in exceptional circumstances when the opposition division permits it, will oral proceedings in opposition be conducted in person.

The president believes that VICO has enabled parties to save on time and money whilst reducing carbon emissions from travelling in person.

Accordingly oral proceedings will only be held in person if requested by a party or at the instigation of the Opposition Division if there are serious reasons against holding the proceedings by video conference. If a party’s request is refused the refusal is not separately appealable.

Given the experience during the pandemic, and as set out in the Pilot Project Final Report [1], the taking of evidence, including hearing witnesses and inspection, has been successfully conducted by VICO and so is not likely to amount to serious reasons for conducting oral proceedings in person. An exception may be where inspection cannot be adequately conducted using video equipment.

Please see here for the official notice from the EPO.

The decision of the President does not affect Oral Proceedings at the Boards of Appeal. Indeed, in the Enlarged Board of Appeal Decision G1/21 the Enlarged Board clearly stated that whilst oral proceedings by VICO were compatible with the right to be heard enshrined in the EPC they were suboptimal compared with in-person hearings and, as such, in-person hearings should, in the absence of a pandemic, be the default option (Reason 45).

Accordingly we do not expect the President’s Decision to have a knock-on effect at the Board of Appeal.

For further information please contact Dr Chris Moore, Head of Oppositions & Appeals.

[1] Pilot Project Final Report November 2022 (here) – over 77% of respondents found oral proceedings to be “good” or “very good”

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

WIPR Diversity Top 100 2025

HGF’s European Patent Attorney Alexandra Wood has been listed in World IP Review’s (WIPR) Diversity Top 100 2025 World IP Review’s Diversity in IP listings 2025 recognises and celebrates people …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article